Transgin™ performs better than these popular brands we currently use, especially in some hard-to-transfect cells. Scientists will get more benefits from them and I’ll recommend
Gaithersburg, MD (PRWEB) November 10, 2010
APS Bio, the bioscience division of America Pharma Source, announces its novel DNA and siRNA transfection products, Transgin™ series, are launched to life science market.
After first generation of in vitro transfection products, EasyTransgater™, was marketed in 2004, APS Bio continues to discover new technology and improve its gene delivery products to address unmet issues from research laboratory to bioproduction process. The introduction of Transgin™ products will provide a better choice for scientists to effectively transfer DNA and siRNA into broad mammalian cells of their interest.
In addition to high transfection efficiency and low toxicity, Transgin™ products exhibit their great flexibility and productivity in high throughput screening and large-scale protein and virus manufacturing. None of animal-derived components in Transgin™ products and no sera inference strengthen them as ideal vehicles for use in full-scale biologic production and drug discovery and development.
"Transgin™ performs better than these popular brands we currently use, especially in some hard-to-transfect cells. Scientists will get more benefits from them and I'll recommend," said a senior scientist from a gene therapy company.
Transgin™ products are available now, and may be ordered online at http://www.apsbio.com or via phone (888-718-8384), via fax (240-597-1402).
About APS Bio:
APS Bio, the bioscience division of America Pharma Source (http://www.apharmas.com), develops, manufactures, and commercializes bio-research tools especially gene delivery products. All R&D efforts focus on discovering and developing innovative technologies and products to solve unmet needs from bioscience community and to accelerate scientific research and drug development. Founded in 2000 in Maryland, USA, APS Bio has expanded its presence into Europe and Asia market. For more information, visit http://www.apsbio.com.